City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting transcription-replication conflicts to combat treatment resistance.

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S.

Oncolytics Biotech is advancing pelareorep, its lead immunotherapy candidate, in metastatic breast, pancreatic, and anal ...

Researchers have identified a new molecular target for treating pancreatic cancer. Scientists focused on transcription-replication conflicts (TRCs), which occur when the mechanisms responsible for ...

Scientists have found a way to 'intercept' pancreatic cancer. By inhibiting the cancer gene FGFR2, they were able to slow tumor formation. By targeting the FGFR2 and EGFR proteins, they were able to ...

Van Andel Institute scientists and collaborators have developed a new method for identifying and classifying pancreatic ...